The fall in HbA1c comes at a cost of rising hypoglycemia-risk, and analogues of long-acting and short-acting insulin reduce nocturnal hypoglycemia and post-prandial glucose, respectively, without benefiting HbA1c levels. Here, INS is linked to Hypoglycemia.